In the combination of 2 companies in the Global 5000, Pfizer Inc. announced the completion of its acquisition of Seagen Inc. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.